Areteia Therapeutics Funding: $350M Series A, Bain Capital
Areteia Therapeutics, based in Chapel Hill, NC, has raised $350M in total through a Series A round backed by Bain Capital.
Areteia Therapeutics funding overview
Areteia Therapeutics is based in Chapel Hill, NC. Areteia Therapeutics has raised $350M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Areteia Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Bain Capital.
Areteia Therapeutics at a glance
Total raised
$350M
Latest round
Series A
Latest round date
January 2024
Headquarters
Chapel Hill, NC
Notable investors
Bain Capital
Frequently asked about Areteia Therapeutics funding
How much has Areteia Therapeutics raised?
Areteia Therapeutics has raised $350M in total disclosed funding across the rounds on record.
Who has invested in Areteia Therapeutics?
Bain Capital are named among the investors backing Areteia Therapeutics.
What was the latest Areteia Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Areteia Therapeutics based?
Areteia Therapeutics is based in Chapel Hill, NC.
When did Areteia Therapeutics last raise?
The last disclosed Areteia Therapeutics round closed in January 2024 at Series A.
Round data for Areteia Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Chapel Hill and backer lists below.
